A Study of BPN14770 in Male Adults (Aged 18 to 45) With Fragile X Syndrome

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
A Randomized, Double-blind, Placebo-controlled, Parallel Group Study of BPN14770 in Male Adults (Aged 18 to 45) with Fragile X Syndrome
Epistemonikos ID: 208e78902232be4066477980ae62c7096f9eac17
First added on: Oct 02, 2023